Tapewire

Nasdaq · USD

AMTX

AEMETIS, INC

Export transactions ↓
Tapewire entity
6595
SEC CIK
0000738214
Parsed reports
212

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2022 Filed Mar 15, 2022 14:49 UTC
BLOCK JOHN RDirector
Exercise / conversionCommon Stock 35,000 $1.72 $60,200.00
Disclosure

SEC source: 0001593968-22-000748 · primary_01.xml · nonDerivative · entry 2

BLOCK JOHN R · CIK 0001055711 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: 35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017.

Read SEC document
March 14, 2022 Filed Mar 15, 2022 14:49 UTC
BLOCK JOHN RDirector
SaleCommon Stock 35,000 $12.12 $424,102.00
Disclosure

SEC source: 0001593968-22-000748 · primary_01.xml · nonDerivative · entry 1

BLOCK JOHN R · CIK 0001055711 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,627

F1 · kind: 35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017 and were sold on 3/14/2022 in the open market.

Read SEC document
February 23, 2022 Filed Feb 24, 2022 17:25 UTC Exercise / conversionOption (right to buy) · Derivative 60,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001593968-22-000522 · primary_01.xml · derivative · entry 4

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2030-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to Exercise 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to Exercise 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

Read SEC document
February 23, 2022 Filed Feb 24, 2022 17:25 UTC Exercise / conversionOption (right to buy) · Derivative 60,000 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001593968-22-000522 · primary_01.xml · derivative · entry 3

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2030-01-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to exercise 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F1 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to exercise 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

Read SEC document
February 23, 2022 Filed Feb 24, 2022 17:25 UTC Exercise / conversionCommon Stock 60,000 $0.60 $36,000.00
Disclosure

SEC source: 0001593968-22-000522 · primary_01.xml · nonDerivative · entry 2

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2022 Filed Feb 24, 2022 17:25 UTC Exercise / conversionCommon Stock 60,000 $0.86 $51,600.00
Disclosure

SEC source: 0001593968-22-000522 · primary_01.xml · nonDerivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 06, 2022 Filed Jan 10, 2022 19:20 UTC
BLOCK JOHN RDirector
GrantCommon Stock 10,371 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000194 · primary_01.xml · nonDerivative · entry 1

BLOCK JOHN R · CIK 0001055711 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,487

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 10,371 RSAs were granted on 1/6/2022 with immediate vest.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 45,116 shares of the Issuers common stock. As of the filing date of this Form 4, the reporting person owned 55,487 shares of the Issuers common stock.

Read SEC document
January 06, 2022 Filed Jan 11, 2022 00:20 UTC
Gupta SanjeevExecutive Vice President, MD
GrantOption (right to buy) · Derivative 100,000 $11.31 Strike: $11.31 $1,131,000.00
Disclosure

SEC source: 0001593968-22-000197 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2032-01-06

F1 · shares: The Reporting person was granted 100,000 ISO options on 1/6/2022 with three year vesting period.

Read SEC document
January 06, 2022 Filed Jan 11, 2022 00:22 UTC GrantCommon Stock 16,371 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000199 · primary_01.xml · nonDerivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,823

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 16,371 RSAs were granted on 1/6/2022 with immediate vest.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 18,452 shares of the Issuers common stock. As of the date of this filing, the Reporting Person beneficially owned 34,823 shares of the Issuers common stock.

Read SEC document
January 06, 2022 Filed Jan 11, 2022 00:20 UTC GrantCommon Stock 10,371 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000198 · primary_01.xml · nonDerivative · entry 1

Boness Naomi Louise · CIK 0001815203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,371

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 10,371 RSAs were granted on 1/6/2022 with immediate vest.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,000 shares of the Issuers common stock. As of the filing date of this Form 4, the reporting person owned 15,371 shares of the Issuers common stock.

Read SEC document
January 06, 2022 Filed Jan 11, 2022 00:20 UTC
FOSTER ANDREW BExecutive Vice President
GrantOption (right to buy) · Derivative 100,000 $11.31 Strike: $11.31 $1,131,000.00
Disclosure

SEC source: 0001593968-22-000196 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2032-01-06

F1 · shares: The Reporting person was granted 100,000 ISO options on 1/6/2022 with three year vesting period.

Read SEC document
January 06, 2022 Filed Jan 11, 2022 00:20 UTC GrantCommon Stock 12,871 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000195 · primary_01.xml · nonDerivative · entry 1

Beebe Lydia I · CIK 0001635208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,871

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 12,371 RSAs were granted on 1/6/2022 with immediate vest.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 120,000 shares of the Issuers common stock. As of the filing date of this Form 4, the reporting person owned 132,371 shares of the Issuers common stock.

Read SEC document
January 06, 2022 Filed Jan 11, 2022 00:20 UTC GrantCommon Stock 10,371 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000193 · primary_01.xml · nonDerivative · entry 1

Simon Timothy Alan · CIK 0001876838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,371

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 10,371 RSAs were granted on 1/6/2022 with immediate vest.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 6,000 shares of the Issuers common stock. As of the filing date of this Form 4, the reporting person owned 16,371 shares of the Issuers common stock.

Read SEC document
January 06, 2022 Filed Feb 24, 2022 11:00 UTC
Waltz ToddExecutive Vice President, CFO
GrantOption (right to buy) · Derivative 100,000 $11.31 Strike: $11.31 $1,131,000.00
Disclosure

SEC source: 0001593968-22-000520 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2032-01-06

F1 · shares: The Reporting person was granted 100,000 ISO options on 1/6/2022 with three year vesting period.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 00:25 UTC PurchaseCommon Stock 1,000 $12.21 $12,210.00
Disclosure

SEC source: 0001593968-21-002562 · primary_01.xml · nonDerivative · entry 1

Simon Timothy Alan · CIK 0001876838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · shares: The Reporting person purchased 1,000 shares in the open market.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 06:15 UTC
BLOCK JOHN RDirector
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-21-002442 · primary_01.xml · nonDerivative · entry 1

BLOCK JOHN R · CIK 0001055711 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,116

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 5000 RSAs were granted on 11/18/2021.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 40,116 shares of the Issuers common stock. As of the filing date of this Form 4, the reporting person owned 45,116 shares of the Issuers common stock.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:16 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-21-002443 · primary_01.xml · nonDerivative · entry 1

Beebe Lydia I · CIK 0001635208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 5000 RSAs were granted on 11/18/2021.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 115,000 shares of the Issuers common stock. As of the filing date of this Form 4, the reporting person owned 120,000 shares of the Issuers common stock.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:12 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-21-002441 · primary_01.xml · nonDerivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,452

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 5000 RSAs were granted on 11/18/2021.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 13,452 shares of the Issuers common stock. As of the date of this filing, the Reporting Person beneficially owned 18,452 shares of the Issuers common stock.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:09 UTC
Gupta SanjeevExecutive Vice President, MD
GrantOption (right to buy) · Derivative 3,066 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002440 · primary_01.xml · derivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,066

Underlying: Common stock and Series B Preferred · 3,066 shares

Expires 2031-11-18

F2 · shares: The Reporting person was granted 3066 ISO options on 11/18/2021 with three year vesting period.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:09 UTC
Gupta SanjeevExecutive Vice President, MD
GrantOption (right to buy) · Derivative 9,434 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002440 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,434

Underlying: Common stock and Series B Preferred · 9,434 shares

Expires 2031-11-18

F1 · shares: The Reporting person was granted 9,434 NQSO options on 11/18/2021 with three year vesting period.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:06 UTC GrantOption (right to buy) · Derivative 10,000 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002438 · primary_01.xml · derivative · entry 2

Simon Timothy Alan · CIK 0001876838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2031-11-18

F3 · shares: The Reporting person was granted 10,000 NQSO options on 11/18/2021 with two year vesting period.

F4 · derivative.exercise_date: 1/8th of the Option Shares vest every three(3)months from the date of the grant.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:06 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-21-002438 · primary_01.xml · nonDerivative · entry 1

Simon Timothy Alan · CIK 0001876838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 5000 RSAs were granted on 11/18/2021.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:05 UTC
Waltz ToddExecutive Vice President, CFO
GrantOption (right to buy) · Derivative 3,312 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002437 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,312

Underlying: Common stock and Series B Preferred · 3,312 shares

Expires 2031-11-18

F3 · shares: The Reporting person was granted 3312 ISO options on 11/18/2021 with three year vesting period.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:05 UTC
Waltz ToddExecutive Vice President, CFO
GrantOption (right to buy) · Derivative 9,188 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002437 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,188

Underlying: Common stock and Series B Preferred · 9,188 shares

Expires 2031-11-18

F1 · shares: The Reporting person was granted 9,188 NQSO options on 11/18/2021 with three year vesting period.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:02 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-21-002434 · primary_01.xml · nonDerivative · entry 1

Boness Naomi Louise · CIK 0001815203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · security: RSA with Immediate vest vesting schedule

F2 · kind: 5000 RSAs were granted on 11/18/2021.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:01 UTC
FOSTER ANDREW BExecutive Vice President
GrantOption (right to buy) · Derivative 3,066 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002433 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,066

Underlying: Common stock and Series B Preferred · 3,066 shares

Expires 2031-11-18

F2 · shares: The Reporting person was granted 3066 ISO options on 11/18/2021 with three year vesting period.

Read SEC document
November 18, 2021 Filed Nov 23, 2021 11:01 UTC
FOSTER ANDREW BExecutive Vice President
GrantOption (right to buy) · Derivative 9,434 $0.00 Strike: $18.53 $0.00
Disclosure

SEC source: 0001593968-21-002433 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,434

Underlying: Common stock and Series B Preferred · 9,434 shares

Expires 2031-11-18

F1 · shares: The Reporting person was granted 9,434 NQSO options on 11/18/2021 with three year vesting period.

Read SEC document
November 18, 2021 Filed Nov 24, 2021 23:06 UTC
MCAFEE ERIC ADirector · Chief Executive Officer
GrantCommon Stock 55,588 $0.00 $0.00
Disclosure

SEC source: 0000947871-21-001242 · ownership.xml · nonDerivative · entry 1

MCAFEE ERIC A · CIK 0001134889 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,837,136

F1 · shares: Represents the number of shares issued to the Reporting Person pursuant to a cash-denominated bonus award from the Issuer, which was fully vested on the grant date.

Read SEC document
November 08, 2021 Filed Nov 8, 2021 23:20 UTC
FOSTER ANDREW BExecutive Vice President
SaleCommon Stock 9,533 $23.09 $220,116.97
Disclosure

SEC source: 0001593968-21-002371 · primary_01.xml · nonDerivative · entry 3

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:20 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 10,833 $0.00 Strike: $3.09 $0.00
Disclosure

SEC source: 0001593968-21-002371 · primary_01.xml · derivative · entry 4

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,831

Underlying: Common stock and Series B Preferred · 10,833 shares

Expires 2031-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:20 UTC
FOSTER ANDREW BExecutive Vice President
SaleCommon Stock 1,300 $23.00 $29,900.00
Disclosure

SEC source: 0001593968-21-002371 · primary_01.xml · nonDerivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,533

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:20 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionCommon Stock 10,833 $3.09 $33,473.97
Disclosure

SEC source: 0001593968-21-002371 · primary_01.xml · nonDerivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2021 Filed Nov 4, 2021 00:10 UTC Exercise / conversionOption (right to buy) · Derivative 10,555 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001593968-21-002359 · primary_01.xml · derivative · entry 6

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common stock and Series B Preferred · 10,555 shares

Expires 2026-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 50% vest Immediately on the grant date and rest 50% vest 1/12th over the three years.

Read SEC document
November 03, 2021 Filed Nov 4, 2021 00:10 UTC SaleCommon Stock 10,555 $21.12 $222,963.82
Disclosure

SEC source: 0001593968-21-002359 · primary_01.xml · nonDerivative · entry 4

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the filing of this Form 4, the Reporting Person beneficially owned 13,452 shares of the Issuers common stock.

Read SEC document
November 03, 2021 Filed Nov 4, 2021 00:10 UTC Exercise / conversionCommon Stock 10,555 $2.54 $26,809.70
Disclosure

SEC source: 0001593968-21-002359 · primary_01.xml · nonDerivative · entry 2

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 02, 2021 Filed Nov 4, 2021 00:10 UTC Exercise / conversionOption (right to buy) · Derivative 9,445 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001593968-21-002359 · primary_01.xml · derivative · entry 5

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,555

Underlying: Common stock and Series B Preferred · 9,445 shares

Expires 2026-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 50% vest Immediately on the grant date and rest 50% vest 1/12th over the three years.

Read SEC document
November 02, 2021 Filed Nov 4, 2021 00:10 UTC SaleCommon Stock 9,445 $21.13 $199,592.68
Disclosure

SEC source: 0001593968-21-002359 · primary_01.xml · nonDerivative · entry 3

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,007

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the filing of this Form 4, the Reporting Person beneficially owned 13,452 shares of the Issuers common stock.

Read SEC document
November 02, 2021 Filed Nov 4, 2021 00:10 UTC Exercise / conversionCommon Stock 9,445 $2.54 $23,990.30
Disclosure

SEC source: 0001593968-21-002359 · primary_01.xml · nonDerivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,897

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2021 Filed Oct 25, 2021 17:20 UTC
FOSTER ANDREW BExecutive Vice President
SaleCommon Stock 11,317 $20.07 $227,177.46
Disclosure

SEC source: 0001593968-21-002297 · primary_01.xml · nonDerivative · entry 4

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

Read SEC document
October 22, 2021 Filed Oct 25, 2021 17:20 UTC
FOSTER ANDREW BExecutive Vice President
SaleCommon Stock 100 $20.00 $2,000.00
Disclosure

SEC source: 0001593968-21-002297 · primary_01.xml · nonDerivative · entry 3

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,317

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

Read SEC document
October 21, 2021 Filed Oct 25, 2021 17:20 UTC
FOSTER ANDREW BExecutive Vice President
SaleCommon Stock 213 $19.96 $4,251.88
Disclosure

SEC source: 0001593968-21-002297 · primary_01.xml · nonDerivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,417

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

Read SEC document
October 20, 2021 Filed Oct 21, 2021 22:21 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 15,000 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001593968-21-002292 · primary_01.xml · derivative · entry 3

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 15,000 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 20, 2021 Filed Oct 21, 2021 22:21 UTC
FOSTER ANDREW BExecutive Vice President
SaleCommon Stock 15,000 $19.08 $286,240.50
Disclosure

SEC source: 0001593968-21-002292 · primary_01.xml · nonDerivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

Read SEC document
October 20, 2021 Filed Oct 21, 2021 22:21 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionCommon Stock 15,000 $1.71 $25,650.00
Disclosure

SEC source: 0001593968-21-002292 · primary_01.xml · nonDerivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 20, 2021 Filed Oct 25, 2021 17:20 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 11,630 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001593968-21-002297 · primary_01.xml · derivative · entry 5

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,850

Underlying: Common stock and Series B Preferred · 11,630 shares

Expires 2026-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

Read SEC document
October 20, 2021 Filed Oct 25, 2021 17:20 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionCommon Stock 11,630 $2.54 $29,540.20
Disclosure

SEC source: 0001593968-21-002297 · primary_01.xml · nonDerivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2021 Filed Oct 20, 2021 16:29 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 25,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001593968-21-002284 · primary_01.xml · derivative · entry 12

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,581

Underlying: Common stock and Series B Preferred · 25,000 shares

Expires 2030-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2021 Filed Oct 20, 2021 16:29 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 8,334 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001593968-21-002284 · primary_01.xml · derivative · entry 11

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,887

Underlying: Common stock and Series B Preferred · 8,334 shares

Expires 2030-01-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2021 Filed Oct 20, 2021 16:29 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 10,000 $0.00 Strike: $0.92 $0.00
Disclosure

SEC source: 0001593968-21-002284 · primary_01.xml · derivative · entry 10

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,696

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2029-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2021 Filed Oct 20, 2021 16:29 UTC
FOSTER ANDREW BExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 27,833 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001593968-21-002284 · primary_01.xml · derivative · entry 9

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,955

Underlying: Common stock and Series B Preferred · 27,833 shares

Expires 2029-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.